Interferon gamma (IFN) ELISpot and FluoroSpot are widely used immune monitoring assays to detect functional cell responses in clinical studies. Recognized for their importance in vaccine development...
In this episode, Dr. Monika Lamba, a pathologist from Q2 Solutions, discusses the transformative role of digital pathology in clinical trials. Despite its origins aiming to streamline trials, it's...
With emerging and re-emerging infectious diseases, the development of new anti-infectives and vaccines presents many challenges. Q2 Solutions understands these challenges in vaccine development. Our...
Laval is the mothership site of Nexelis, a Q2 Solutions Company, with a history of success in developing vaccine technology for a broad array of infectious diseases. Download our factsheet to learn...